Genoss Co., Ltd.

This study is observing how well a new type of heart stent works and how safe it is for patients who have had a heart attack or unstable chest pain (acute coronary syndrome). The stent, called GENOSS SES, is already in use, but researchers want to see its real-world performance i…

This study is observing how well a specific type of drug-coated heart stent (GENOSS SES) works and how safe it is for people with blocked heart arteries. It will follow over 1,100 patients who receive this stent as part of their standard care. The main goal is to see how many pat…

This study aims to see how safe and effective a special drug-coated balloon is for treating blocked leg arteries over one year. It will follow 300 patients who have already received this balloon procedure in real-world hospital settings. Researchers will track whether the arterie…

This study is observing how well a special balloon works for people with new blockages in their small heart arteries. The balloon is coated with a drug (paclitaxel) meant to help keep the artery open after it's stretched. Researchers will follow 3000 patients for up to 3 years to…

This study is observing how well a new type of heart stent works in everyday medical practice. The stent, called GENOSS DES, is coated with a medicine and a polymer that dissolves over time. Researchers are tracking 1,000 patients with blocked heart arteries to see if the stent s…

This study is observing how well a special drug-coated balloon works to treat blocked arteries in the leg. It will follow 200 patients for one year after their procedure to see if the artery stays open and to check for any safety issues. The goal is to gather real-world informati…

This study is observing 1,000 patients with blockages in multiple heart arteries who receive a specific type of drug-coated stent. The goal is to see how safe and effective this stent is over time by tracking heart-related problems. It is an observational study, meaning patients …

This study is testing a new medical device called the Genoss® SCB, which is a drug-coated balloon, to see if it works as well as an existing treatment for a condition where a previously placed heart stent becomes narrowed again. The trial will enroll 94 patients who have this re-…